We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
The Zacks Analyst Blog Highlights: Bank of America, Cisco Systems, Boeing, Citigroup and The Progressive Corp
Read MoreHide Full Article
For Immediate Release
Chicago, IL – March 12, 2021 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include: Bank of America Corporation (BAC - Free Report) , Cisco Systems, Inc (CSCO - Free Report) , The Boeing Company (BA - Free Report) , Citigroup Inc. (C - Free Report) and The Progressive Corporation (PGR - Free Report) .
Here are highlights from Thursday’s Analyst Blog:
Top Research Reports for Bank of America, Cisco and Boeing
The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 16 major stocks, including Bank of America, Cisco Systems and The Boeing Company. These research reports have been hand-picked from the roughly 70 reports published by our analyst team today.
Bank of America shares have outperformed the Zacks Major Regional Banks industry over the past year (+82.3% vs. +73.9%). The Zacks analyst believes that opening of new branches, improvement in digital offerings and efforts to manage expenses are expected to aid the company's profitability in the quarters ahead.
The company is likely to continue to enhance shareholder value through sustained capital deployments. However, near-zero interest rates and no near-term chance of any change in the same are expected to keep hurting the bank’s margins and interest income to an extent.
Further, the company's high dependence on the volatile nature of the capital markets to generate fee income makes us apprehensive.
Shares of Cisco have gained +20.2% in the last six months against the Zacks Computer Networking industry’s gain of +20.1%. The Zacks analyst believes that Cisco is well-positioned to benefit from robust adoption of identity and access, advanced threat and unified threat management security solutions amid high growth in Internet traffic.
Further, ongoing momentum in Webex video conferencing and business productivity offerings on account of COVID-19 induced work-from-home demand environment remains noteworthy.
Moreover, strong demand for Catalyst 9000 family of switches, and recovery across Europe, Middle East and Africa (EMEA), holds promise. Nonetheless, weakness in the enterprise end markets and coronavirus crisis-led supply chain constraints is likely to weigh on revenues, at least in the near term.
Boeing shares have gained +10.6% over the past three months against the Zacks Aerospace & Defense industry’s gain of +3.5%. The Zacks analyst believes that long-term prospects of the global services unit and increasing fiscal defense budget will drive Boeing's growth.
Further, its revenue exposure is spread across more than 90 countries around the globe. While Boeing’s commercial business has not been performing well for the past couple of quarters on account of lower deliveries, the outlook for the company's defense business remains optimistic.
However, Airbus beat Boeing as the world's largest plane maker in 2019 for the first time and again in 2020. Impact of COVID-19 on global air traffic has put Boeing’s 777X product line in jeopardy. Moreover, the company had to reduce its production rate for its 787 and 777 jet programs due to the pandemic.
Other noteworthy reports we are featuring today include Citigroup and The Progressive.
Breakout Biotech Stocks with Triple-Digit Profit Potential
The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.
Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +50%, +83% and +164% in as little as 2 months. The stocks in this report could perform even better.
Past performance is no guarantee of future results. Inherent in any investment is the potential for loss. This material is being provided for informational purposes only and nothing herein constitutes investment, legal, accounting or tax advice, or a recommendation to buy, sell or hold a security. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. It should not be assumed that any investments in securities, companies, sectors or markets identified and described were or will be profitable. All information is current as of the date of herein and is subject to change without notice. Any views or opinions expressed may not reflect those of the firm as a whole. Zacks Investment Research does not engage in investment banking, market making or asset management activities of any securities. These returns are from hypothetical portfolios consisting of stocks with Zacks Rank = 1 that were rebalanced monthly with zero transaction costs. These are not the returns of actual portfolios of stocks. The S&P 500 is an unmanaged index. Visit https://www.zacks.com/performance for information about the performance numbers displayed in this press release.
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
The Zacks Analyst Blog Highlights: Bank of America, Cisco Systems, Boeing, Citigroup and The Progressive Corp
For Immediate Release
Chicago, IL – March 12, 2021 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include: Bank of America Corporation (BAC - Free Report) , Cisco Systems, Inc (CSCO - Free Report) , The Boeing Company (BA - Free Report) , Citigroup Inc. (C - Free Report) and The Progressive Corporation (PGR - Free Report) .
Here are highlights from Thursday’s Analyst Blog:
Top Research Reports for Bank of America, Cisco and Boeing
The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 16 major stocks, including Bank of America, Cisco Systems and The Boeing Company. These research reports have been hand-picked from the roughly 70 reports published by our analyst team today.
You can see all of today’s research reports here >>>
Bank of America shares have outperformed the Zacks Major Regional Banks industry over the past year (+82.3% vs. +73.9%). The Zacks analyst believes that opening of new branches, improvement in digital offerings and efforts to manage expenses are expected to aid the company's profitability in the quarters ahead.
The company is likely to continue to enhance shareholder value through sustained capital deployments. However, near-zero interest rates and no near-term chance of any change in the same are expected to keep hurting the bank’s margins and interest income to an extent.
Further, the company's high dependence on the volatile nature of the capital markets to generate fee income makes us apprehensive.
(You can read the full research report on Bank of America here >>>)
Shares of Cisco have gained +20.2% in the last six months against the Zacks Computer Networking industry’s gain of +20.1%. The Zacks analyst believes that Cisco is well-positioned to benefit from robust adoption of identity and access, advanced threat and unified threat management security solutions amid high growth in Internet traffic.
Further, ongoing momentum in Webex video conferencing and business productivity offerings on account of COVID-19 induced work-from-home demand environment remains noteworthy.
Moreover, strong demand for Catalyst 9000 family of switches, and recovery across Europe, Middle East and Africa (EMEA), holds promise. Nonetheless, weakness in the enterprise end markets and coronavirus crisis-led supply chain constraints is likely to weigh on revenues, at least in the near term.
(You can read the full research report on Cisco here >>>)
Boeing shares have gained +10.6% over the past three months against the Zacks Aerospace & Defense industry’s gain of +3.5%. The Zacks analyst believes that long-term prospects of the global services unit and increasing fiscal defense budget will drive Boeing's growth.
Further, its revenue exposure is spread across more than 90 countries around the globe. While Boeing’s commercial business has not been performing well for the past couple of quarters on account of lower deliveries, the outlook for the company's defense business remains optimistic.
However, Airbus beat Boeing as the world's largest plane maker in 2019 for the first time and again in 2020. Impact of COVID-19 on global air traffic has put Boeing’s 777X product line in jeopardy. Moreover, the company had to reduce its production rate for its 787 and 777 jet programs due to the pandemic.
(You can read the full research report on Boeing here >>>)
Other noteworthy reports we are featuring today include Citigroup and The Progressive.
Breakout Biotech Stocks with Triple-Digit Profit Potential
The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.
Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +50%, +83% and +164% in as little as 2 months. The stocks in this report could perform even better.
See these 7 breakthrough stocks now>>
Media Contact
Zacks Investment Research
800-767-3771 ext. 9339
support@zacks.com
https://www.zacks.com
Past performance is no guarantee of future results. Inherent in any investment is the potential for loss. This material is being provided for informational purposes only and nothing herein constitutes investment, legal, accounting or tax advice, or a recommendation to buy, sell or hold a security. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. It should not be assumed that any investments in securities, companies, sectors or markets identified and described were or will be profitable. All information is current as of the date of herein and is subject to change without notice. Any views or opinions expressed may not reflect those of the firm as a whole. Zacks Investment Research does not engage in investment banking, market making or asset management activities of any securities. These returns are from hypothetical portfolios consisting of stocks with Zacks Rank = 1 that were rebalanced monthly with zero transaction costs. These are not the returns of actual portfolios of stocks. The S&P 500 is an unmanaged index. Visit https://www.zacks.com/performance for information about the performance numbers displayed in this press release.